Visfatin increases the invasive potential of ovarian granulosa tumor spheroids by reprogramming glucose metabolism

in Reproduction
Authors:
Justyna Gogola-MrukJ Gogola-Mruk, Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Kraków Faculty of Biology, Krakow, Poland

Search for other papers by Justyna Gogola-Mruk in
Current site
Google Scholar
PubMed
Close
,
Weronika MarynowiczW Marynowicz, Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, Jagiellonian University in Kraków Faculty of Biology, Krakow, Poland

Search for other papers by Weronika Marynowicz in
Current site
Google Scholar
PubMed
Close
,
Kinga KrawczykK Krawczyk, Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, , Jagiellonian University in Kraków Faculty of Biology, Krakow, Poland

Search for other papers by Kinga Krawczyk in
Current site
Google Scholar
PubMed
Close
, and
Anna PtakA Ptak, Laboratory of Physiology and Toxicology of Reproduction, Institute of Zoology and Biomedical Research, , Jagiellonian University in Kraków Faculty of Biology, Krakow, Poland

Search for other papers by Anna Ptak in
Current site
Google Scholar
PubMed
Close
View More View Less

Correspondence: Justyna Gogola-Mruk, Email: justyna.gogola@uj.edu.pl
Restricted access

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $0.01
USD  $0.01

USD  $1.00
USD  $1.00

Visfatin is an adipokine with nicotinamide phosphoribosyltransferase (NAMPT) activity, the concentration of which is higher in ascitic fluid than in serum, and is associated with ovarian cancer peritoneal dissemination. Furthermore, potentially important effects of visfatin on glucose metabolism have been previously reported. However, the mechanism underlying the effects of visfatin on ovarian cancer cell invasion, and whether this involves altered glucose metabolism, has not been elucidated. Here we tested the hypothesis that visfatin, which can reprogram cancer metabolism, promotes invasion by ovarian cancer spheroids. Visfatin increased glucose transporter (GLUT)1 expression and glucose uptake in adult granulosa cell tumor-derived spheroid cells (KGN), and also increased the activities of hexokinase 2 and lactate dehydrogenase. We showed a visfatin-induced increase in glycolysis in KGN cells. Moreover, visfatin increased the potential invasiveness of KGN spheroid cells by upregulating MMP2 (matrix metalloproteinase 2) and downregulating CLDN3 and CLDN4 (claudin 3 and 4) gene expression. Interestingly, an inhibitor of GLUT1 (STF-31) and lactate dehydrogenase (LDHA) abolished the stimulatory effect of visfatin on the potential invasiveness of KGN cells. More importantly, silencing expression of the NAMPT gene in KGN cells demonstrated its important effect on glycolysis and invasiveness in adult granulosa cell tumor cells. In summary, visfatin appears to increase adult granulosa cell tumor invasiveness through effects on glucose metabolism, and to be an important regulator of glucose metabolism in these cells

 

  • Collapse
  • Expand

     An official journal of

    Society for Reproduction and Fertility